Cargando…

Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population

BACKGROUND: Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes f...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chi-Cheng, Tu, Shih-Hsin, Lien, Heng-Hui, Jeng, Jaan-Yeh, Liu, Jung-Sen, Huang, Ching-Shui, Wu, Yih-Yiing, Liu, Chih-Yi, Lai, Liang-Chuan, Chuang, Eric Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445863/
https://www.ncbi.nlm.nih.gov/pubmed/23046482
http://dx.doi.org/10.1186/1479-5876-10-S1-S10
_version_ 1782243875962748928
author Huang, Chi-Cheng
Tu, Shih-Hsin
Lien, Heng-Hui
Jeng, Jaan-Yeh
Liu, Jung-Sen
Huang, Ching-Shui
Wu, Yih-Yiing
Liu, Chih-Yi
Lai, Liang-Chuan
Chuang, Eric Y
author_facet Huang, Chi-Cheng
Tu, Shih-Hsin
Lien, Heng-Hui
Jeng, Jaan-Yeh
Liu, Jung-Sen
Huang, Ching-Shui
Wu, Yih-Yiing
Liu, Chih-Yi
Lai, Liang-Chuan
Chuang, Eric Y
author_sort Huang, Chi-Cheng
collection PubMed
description BACKGROUND: Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes from 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) as well as clinical presentations of each molecualr subtype in Han Chinese population. METHODS: In all, 169 breast cancer samples (44 from Taiwan and 125 from China) of Han Chinese population were gathered, and the gene expression features corresponding to 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) were retrieved for molecular subtype prediction. RESULTS: For Sørlie 500 and Hu 306 intrinsic gene set, mean-centring of genes and distance-weighted discrimination (DWD) remarkably reduced the number of unclassified cases. Regarding pairwise agreement, the highest predictive consistency was found between Hu 306 and PAM50. In all, 150 and 126 samples were assigned into identical subtypes by both Hu 306 and PAM50 genes, under mean-centring and DWD. Luminal B tended to show a higher nuclear grade and have more HER2 over-expression status than luminal A did. No basal-like breast tumours were ER positive, and most HER2-enriched breast tumours showed HER2 over-expression, whereas, only two-thirds of ER negativity/HER2 over-expression tumros were predicted as HER2-enriched molecular subtype. For 44 Taiwanese breast cancers with survival data, a better prognosis of luminal A than luminal B subtype in ER-postive breast cancers and a better prognosis of basal-like than HER2-enriched subtype in ER-negative breast cancers was observed. CONCLUSIONS: We suggest that the intrinsic signature Hu 306 or PAM50 be used for breast cancers in the Han Chinese population during molecular subtyping. For the prognostic value and decision making based on intrinsic subtypes, further prospective study with longer survival data is needed.
format Online
Article
Text
id pubmed-3445863
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34458632012-09-21 Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population Huang, Chi-Cheng Tu, Shih-Hsin Lien, Heng-Hui Jeng, Jaan-Yeh Liu, Jung-Sen Huang, Ching-Shui Wu, Yih-Yiing Liu, Chih-Yi Lai, Liang-Chuan Chuang, Eric Y J Transl Med Proceedings BACKGROUND: Breast cancer is a heterogeneous disease in terms of transcriptional aberrations; moreover, microarray gene expression profiles had defined 5 molecular subtypes based on certain intrinsic genes. This study aimed to evaluate the prediction consistency of breast cancer molecular subtypes from 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) as well as clinical presentations of each molecualr subtype in Han Chinese population. METHODS: In all, 169 breast cancer samples (44 from Taiwan and 125 from China) of Han Chinese population were gathered, and the gene expression features corresponding to 3 distinct intrinsic gene sets (Sørlie 500, Hu 306 and PAM50) were retrieved for molecular subtype prediction. RESULTS: For Sørlie 500 and Hu 306 intrinsic gene set, mean-centring of genes and distance-weighted discrimination (DWD) remarkably reduced the number of unclassified cases. Regarding pairwise agreement, the highest predictive consistency was found between Hu 306 and PAM50. In all, 150 and 126 samples were assigned into identical subtypes by both Hu 306 and PAM50 genes, under mean-centring and DWD. Luminal B tended to show a higher nuclear grade and have more HER2 over-expression status than luminal A did. No basal-like breast tumours were ER positive, and most HER2-enriched breast tumours showed HER2 over-expression, whereas, only two-thirds of ER negativity/HER2 over-expression tumros were predicted as HER2-enriched molecular subtype. For 44 Taiwanese breast cancers with survival data, a better prognosis of luminal A than luminal B subtype in ER-postive breast cancers and a better prognosis of basal-like than HER2-enriched subtype in ER-negative breast cancers was observed. CONCLUSIONS: We suggest that the intrinsic signature Hu 306 or PAM50 be used for breast cancers in the Han Chinese population during molecular subtyping. For the prognostic value and decision making based on intrinsic subtypes, further prospective study with longer survival data is needed. BioMed Central 2012-09-19 /pmc/articles/PMC3445863/ /pubmed/23046482 http://dx.doi.org/10.1186/1479-5876-10-S1-S10 Text en Copyright ©2012 Huang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Huang, Chi-Cheng
Tu, Shih-Hsin
Lien, Heng-Hui
Jeng, Jaan-Yeh
Liu, Jung-Sen
Huang, Ching-Shui
Wu, Yih-Yiing
Liu, Chih-Yi
Lai, Liang-Chuan
Chuang, Eric Y
Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
title Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
title_full Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
title_fullStr Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
title_full_unstemmed Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
title_short Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
title_sort prediction consistency and clinical presentations of breast cancer molecular subtypes for han chinese population
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445863/
https://www.ncbi.nlm.nih.gov/pubmed/23046482
http://dx.doi.org/10.1186/1479-5876-10-S1-S10
work_keys_str_mv AT huangchicheng predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT tushihhsin predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT lienhenghui predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT jengjaanyeh predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT liujungsen predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT huangchingshui predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT wuyihyiing predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT liuchihyi predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT lailiangchuan predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation
AT chuangericy predictionconsistencyandclinicalpresentationsofbreastcancermolecularsubtypesforhanchinesepopulation